| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/13/2006 | WO2005100403A3 Antibodies to erythropoietin receptor and uses thereof |
| 07/13/2006 | WO2005079389A3 In vivo assembly of transcription units |
| 07/13/2006 | WO2005069845A3 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby |
| 07/13/2006 | WO2005033286A3 Compositions and methods for synthesizing, purifying and detecting biomolecules |
| 07/13/2006 | WO2004092197A8 Amyloid-specific peptides and uses thereof |
| 07/13/2006 | WO2004090105A3 Modified polynucleotides for use in rna interference |
| 07/13/2006 | WO2004011667A3 Geranyl diphosphate synthase molecules, and nucleic acid molecules encoding same |
| 07/13/2006 | WO2003083073A3 Binding assay employing gpcr 192 |
| 07/13/2006 | US20060156444 Cotton cultivar 04Y341 |
| 07/13/2006 | US20060156443 Precise breeding |
| 07/13/2006 | US20060156441 Chimeric gene comprising polynucleotide operably linked to a regulatory sequence; cells, plants, seeds, vectors; transformation of host cell; gene expression and engineering |
| 07/13/2006 | US20060156440 Method for enhancing the nutritive value of plant extract |
| 07/13/2006 | US20060156439 Encodes a gene product that confers herbicide, salt, pathogen, or insect resistance |
| 07/13/2006 | US20060156438 Protein containing a burp domain |
| 07/13/2006 | US20060156437 Of given sequence; use in combination with other enzymes for hydrolysis of starch; pH and temperature optimum, thermostability |
| 07/13/2006 | US20060156436 Transgenic plant having fructooligosaccharide accumulated therein and process for constructing |
| 07/13/2006 | US20060156435 Fatty acid desaturases from fungi |
| 07/13/2006 | US20060156434 Xenorhabdus TC proteins and genes for pest control |
| 07/13/2006 | US20060156433 Defensin-encoding nucleic acid molecules, uses therefor and transgenic plants comprising same |
| 07/13/2006 | US20060156432 Insecticidal proteins derived from Bacillus thuringiensis |
| 07/13/2006 | US20060156431 L-gulose dependent vitamin C synthesis |
| 07/13/2006 | US20060156430 Novel cytochrome P450 monooxygenase |
| 07/13/2006 | US20060156429 Expression cassettes for mesophyll- and/or epidermis-preferential expression in plants |
| 07/13/2006 | US20060156428 A construct, comprising an expression cassette for reducing gene expression in a plant; using a polynucleotide that is not operably linked to a promoter and a terminator but is instead operably linked to two convergently-oriented promoters |
| 07/13/2006 | US20060156427 Structure-based designed herbicide resistant products |
| 07/13/2006 | US20060156425 GNG4 gene disruptions, compositions and methods related thereto |
| 07/13/2006 | US20060156424 Quiescent cell populations for nuclear transfer |
| 07/13/2006 | US20060156423 Method of screening antiobesity agents and animal model of obesity |
| 07/13/2006 | US20060156419 Mouse model for autoimmune disorders |
| 07/13/2006 | US20060155484 Ratio-based oligonucleotide probe selection |
| 07/13/2006 | US20060155123 Donor dye with absorption maxima at 250-450 nm wavelength; acceptor dye emitting light with maxima greater than 500 nm. in response to absorbing energy emitted by doner; especially with donor and acceptor dyes linked together |
| 07/13/2006 | US20060155118 Affinity purification system using troponin molecules as affinity ligands |
| 07/13/2006 | US20060155115 Multivalent T cell receptor complexes |
| 07/13/2006 | US20060155111 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 07/13/2006 | US20060155109 agonist; a memory function improving agent, appetite regulator; an uterine, renal, testis, spleen, heart, prostatic or skeletal muscle function improving agent; antiobesity agent, antiabetic |
| 07/13/2006 | US20060154896 Phosphorylated dextrans |
| 07/13/2006 | US20060154892 Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 07/13/2006 | US20060154890 Immunostimulatory nucleic acids for the treatment of asthma and allergy |
| 07/13/2006 | US20060154888 LNA oligonucleotides and the treatment of cancer |
| 07/13/2006 | US20060154887 Use of apoptosis-specific eIF-5A siRNAs and antisense polynucleotides to inhibit/suppress an inflammatory response |
| 07/13/2006 | US20060154886 Regulatory elements in the 5' region of the VR1 gene |
| 07/13/2006 | US20060154883 Nonsense-mediated mrna decay |
| 07/13/2006 | US20060154882 Methods for blocking adipocyte differentiation and triglyceride accumulation with g-alpha-i3 inhibitors |
| 07/13/2006 | US20060154870 Method for prevention or treatment of diseases or disorders related to excessive formation of vascular tissue or blood vessels |
| 07/13/2006 | US20060154856 NADPH oxidase inhibition pharmacotherapies for Obstructive Sleep Apnea syndrome and its associated morbidities |
| 07/13/2006 | US20060154844 Use of endoglucanase 6 in saccharification of biomass; fermenation to ethanol |
| 07/13/2006 | US20060154843 Neutral cellulase catalytic core and method of producing same |
| 07/13/2006 | US20060154842 Lipoxygenase |
| 07/13/2006 | US20060154370 Efficient gene suppression using a transfer RNA promoter in herpes virus vectors to deliver small interference RNAs |
| 07/13/2006 | US20060154369 Promoter sequences from WSSV immediate early genes and their uses in recombinant DNA techniques |
| 07/13/2006 | US20060154368 Transgenic mice containing CX2 gene disruptions |
| 07/13/2006 | US20060154355 Genetic engineering using functional nucleic acid or a nucleic acid molecule which confers resistance to an antibiotic or a herbicide; high efficiency and stable expression |
| 07/13/2006 | US20060154354 High yield pertussis vaccine production strain and method for making same |
| 07/13/2006 | US20060154351 Gene participating in acetic acid tolerance, acetic acid bacteria bred using the gene, and process for producing vinegar with the use of the acetic acid bacterium |
| 07/13/2006 | US20060154349 Production of coenzyme q-10 |
| 07/13/2006 | US20060154348 Process for producing HMG-CoA reductase inhibitors |
| 07/13/2006 | US20060154345 Metabolic engineering of amino acid production |
| 07/13/2006 | US20060154344 Escherichia bacterium, modified so that a malic enzyme does not function normally in the bacterium, culturing |
| 07/13/2006 | US20060154342 Acid fungal proteases |
| 07/13/2006 | US20060154341 Sample processing vessels |
| 07/13/2006 | US20060154339 Novel clock gene BMAL2 |
| 07/13/2006 | US20060154338 Novel antibiotic alternatives |
| 07/13/2006 | US20060154337 Gene encoding chondroitinase ABC and uses therefor |
| 07/13/2006 | US20060154335 Novel members of the steroid/thyroid superfamily and uses therefor |
| 07/13/2006 | US20060154330 Akap18 delta, a novel splicing variant of a protein kinase a anchor protein and the use of the same |
| 07/13/2006 | US20060154329 Expression system |
| 07/13/2006 | US20060154307 Receptor assay |
| 07/13/2006 | US20060154298 Method of synthesis and testing of combinatorial libraries using microcapsules |
| 07/13/2006 | US20060154296 Pigment protein |
| 07/13/2006 | US20060154295 Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy |
| 07/13/2006 | US20060154294 Interleukin-18 binding proteins, their preparation and use |
| 07/13/2006 | US20060154292 Novel 16SrRNA gene data and probes useful for detecting and quantitating microorganism from natural environment |
| 07/13/2006 | US20060154291 Reagents and methods useful for detecting diseases of the breast |
| 07/13/2006 | US20060154289 Method for determining metabolic flux affecting substance production |
| 07/13/2006 | US20060154288 Deriving nucleotide sequence information from individual polynucleotide molecules |
| 07/13/2006 | US20060154283 Computer-directed assembly of a polynucleotide encoding a target polypeptide |
| 07/13/2006 | US20060154279 Using tumor antigen derived gene-14 (TADG-14) protein as diagnostic indicator of cell proliferaive disorders |
| 07/13/2006 | US20060154277 Compositions and methods for diagnosing or treating psoriasis |
| 07/13/2006 | US20060154274 Topographic genotyping |
| 07/13/2006 | US20060154271 Enzymatic nucleic acid treatment of diseases or conditions related to levels of IKK-gamma and PKR |
| 07/13/2006 | US20060154269 Cleavage of nucleic acids |
| 07/13/2006 | US20060154266 Assays for TERT promoter modulatory agents |
| 07/13/2006 | US20060154247 Methods,compositions and kits for cell separation |
| 07/13/2006 | US20060154244 Novel g-protein coupled receptor |
| 07/13/2006 | US20060154240 utilizing a retroviral integrase complex comprising a recombinant integrase having a domain comprising a non-native protein binding site, and a DNA binding protein comprising a DNA binding domain and a peptide binding domain that binds the non-native protein binding site of the recombinant integrase |
| 07/13/2006 | US20060154237 Soluble rna polymerase protein and methods for the use thereof |
| 07/13/2006 | US20060153902 Genration of phytase for use in animal feeds; obtain genetically engineered yeast, express vector, recover phytase |
| 07/13/2006 | US20060153884 can be associated with the peptide 111-136 of HARP; cancer treatment |
| 07/13/2006 | US20060153881 P. falciparum erythrocyte binding protein-2 (EBP2) Region II (RII), used to induce an immune response to Plasmodium falciparum merozoites to treat diseases such as malaria |
| 07/13/2006 | US20060153879 Streptococcal C5a peptidase vaccine |
| 07/13/2006 | US20060153875 Novel brachyspira hyodyseteriae vaccine |
| 07/13/2006 | US20060153874 Recombinant poxvirus comprising at least two compox ati promoters |
| 07/13/2006 | US20060153870 Method for the recovery of non-segmented, nagative-stranded RNA viruses from cDNA |
| 07/13/2006 | US20060153868 Process for the preparation of an improved Brucella strain plasmid to develop the strain and the vaccine comprising the said strain |
| 07/13/2006 | US20060153866 Human immunodeficiency virus-1 group O/M envelope polypeptide fusion for use as evaluative tool in diagnosing viral infection |
| 07/13/2006 | US20060153865 Antigenic peptides |
| 07/13/2006 | US20060153864 truncated papillomavirus L1 protein consisting of an amino acid sequence having one or more carboxy terminal amino acid residues deleted from a full length L1 amino acid sequence, and amino acid residues from a second protein replacing deleted amino acid residues in the truncated L1 protein. |
| 07/13/2006 | US20060153849 Methods of treatment with an antibody that suppresses growth differentiation factor-14 activity |
| 07/13/2006 | US20060153841 Nucleotide sequence which hybridizes to the complement of the specific nucleic acid molecule over its full length under conditions of incubation and encodes a polypeptide which costimulates T cell proliferation in vitro |
| 07/13/2006 | US20060153837 Treating autoimmune diseases with humanized anti-CD401 antibodies |